Esra Akbay, PhD, UT Southwestern Medical Center
Monica Guzman, PhD, Weill Cornell Medicine
Hilton Denver Inverness
200 Inverness Drive West
Englewood, CO 80112
Meeting #: Refer to your packet.
Hours: 8:00am – 8:00 pm EST M-F
International : 623-516-6140
Modern immunotherapy concepts have changed cancer treatment paradigms, such as immune checkpoint blockade, chimeric antigen receptor (CAR) T cells, and antibody-based therapies have made rapid progress in the past 10 years and are currently used to treat many cancers. Immune checkpoint inhibition circumvents tumor-induced suppression of cytotoxic T cell function. Adoptive transfer of T cells expressing chimeric antigen receptors (CARs) are currently approved treat CD19-positive cancers. However, only a fraction of patients responds, especially in the field of solid tumors as, for example, the immune microenvironment plays a critical role in disease progression and outcomes as it can induce immune suppressive signals that prevent immune-surveillance and allow malignant cells to persist. Therefore, combination treatments using different kind of immunotherapies targeting multiple checkpoints are necessary for more effective responses. Discussing all the components that are known to play a role in the mechanisms of immune escape and the emerging concepts for therapeutic interventions in a multidisciplinary setting will lead to the implementation of rationally designed trials to better harness immune system for the benefit of cancer patients.
|Andrea Cossarizza, MD, PhD||University of Modena and Reggio Emilia|
|Lorenzo Galluzzi, PhD||Weill Cornell Medical College|
|Juliet Gray, MA, MB BS, FRCPCH, PhD||University of South Hampton|
|Annette Künkele, MD||Charite - University Hospital Berlin|
|Fabiana Perna, MD PhD||Indiana University|
|David Raulet, PhD||University of California Berkeley|
|Antoni Ribas, MD, PhD||University of California Los Angeles|
|Ankur Singh, PhD||Georgia Institute of Technology|
|Marcel Van Den Brink, MD, PhD||Memorial Sloan Kettering Cancer Center|
|Loems Ziegler-Heitbrock, MD||Helmholtz Zentrum München|
Denver International Airport (DIA) is approximately 1 hour from the meeting location.
International participants are welcome to arrive on Wednesday to minimize chances for missed or delayed connections.Submit Travel Form
The abstracts should be only one or two paragraphs outlining the theme of your presentation and should reflect the objective and spirit of the meeting (see above). Abstracts will be circulated about one week before the meeting. The meeting organizer will start requesting them a month before the meeting.Submit Abstract
For more than 30 years, the Forbeck Foundation has proven to be an excellent steward of donor funds and has remained focused on executing its mission. Interested in sponsoring this Forum? Contact us today for more information!